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Abstract: A current advance in nanotechnology is the selective targeting of therapeutics by 
external magnetic ﬁ  eld-guided delivery. This is an important area of research in medicine. The 
use of magnetic forces results in the formation of agglomerated structures in the ﬁ  eld region. 
The transport characteristics of these agglomerated structures are explored. A nonintrusive 
method based on in situ light-scattering techniques is used to characterize the velocity of such 
particles in a magnetic ﬁ  eld gradient. A transport model for the chain-like agglomerates is 
developed based on these experimental observations. The transport characteristics of magnetic 
nanoparticle drug carriers are then explored in gel-based simulated models of the brain. Results 
of such measurements demonstrate decreased diffusion of magnetic nanoparticles when placed 
in a high magnetic ﬁ  eld gradient.
Keywords: nanoparticle ferroﬂ  uid, gel-brain model, drug delivery, magnetic agglomeration, 
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Introduction
The ability to precisely target and control the release of a drug to any tissue or region 
in the body with great speciﬁ  city is an important objective of therapeutic delivery. 
Systematic research over the past few decades has been performed to use magnetic 
ﬁ  elds to steer and target drugs using ferroﬂ  uids that can reversibly bind therapeutic 
agents.1,2 The concept of magnetically guided targeted drug delivery is simple, wherein 
the drug of choice is bound to a particle with a magnetic core, and an external magnet is 
used to guide the composite to the desired point in the body and/or deposit in a certain 
location for controlled release of the drug. Many studies have been done to examine 
the targeting of therapeutics in animal models.3,4 Lubbe and colleagues5 were the ﬁ  rst 
group to perform a clinical trial using magnetic drug targeting in a small population of 
14 patients with advanced solid tumors. Hafeli6 has highlighted the requirement of 
a large and precisely deﬁ  ned magnetic ﬁ  eld gradient, as well as the need for the use 
of small sized particles with a high magnetic susceptibility. Though larger sized 
particles experience a higher magnetic force (magnetic moment is proportional to the 
third power of diameter), they are also cleared more rapidly from the blood by the 
body’s reticulo-endothelial system (RES).7 Mykhaylyk and colleagues8 suggested that 
particles should be smaller than 400–500 nm, and perhaps even as small as 150 nm to 
avoid fenestrations in the liver and spleen. Thus, ﬁ  nding an optimal size is essential 
and ideal carriers should be as large as possible (to experience larger magnetic forces) 
but small enough to move into the desired target region and avoid clearance.
The capacity to direct therapeutic agents to speciﬁ  c areas in the brain is important 
in the treatment of a number of diseases such as Parkinson’s disease and cancer.9 
Much of the current research in this area centers on convection-enhanced delivery 
(CED), which utilizes positive pressure infusion directly into the target site, but lacks 
speciﬁ  city of the volume of distribution.10,11 The combination of CED and use of International Journal of Nanomedicine 2009:4 10
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magnetic forces to enhance targeting may enable delivery of 
particles to speciﬁ  c regions or help restrict the particles within 
pre-deﬁ  ned boundaries, thus, effectively reducing clearance 
and minimizing adverse interactions with healthy tissue.12–14 
To accomplish this, the magnetic force generated on the 
particles would need to be sufﬁ  cient to overcome diffusion 
and convective ﬂ  ow in the brain. The use of chaining and 
the creation of particle agglomerates for therapeutic delivery 
has been reported by Forbes.12 They used superparamagnetic 
particles that agglomerated in the magnetic ﬁ  eld gradient, and 
thus overcame convective and diffusive forces to remain in 
the blood vessel and eventually deposit on the walls.
To effectively develop such a system, it is important 
to evaluate the transport characteristics by understanding 
the various forces acting on the particles. The velocity of 
the nanoparticles are dependent on the magnetic and drag 
forces that act on the particles.13 An additional complexity 
that needs to be accounted for is that magnetic particles tend 
to agglomerate in a magnetic ﬁ  eld gradient and create larger 
chain-like structures.14–17 If the force balance calculations 
are done based on single particle analysis,18,19 the effective 
magnetic force and velocity of the particles will be under-
predicted. While there have been experimental demonstrations 
of such strategies,20 no detailed studies have been conducted 
to develop an understanding of the increased magnetic forces 
due to agglomeration and the reduction of transport.
This paper reports a detailed evaluation of velocity of 
magnetic particles undergoing simultaneous agglomeration in 
a magnetic ﬁ  eld gradient. The change in morphology (shape) of 
the resultant agglomerate is accounted for in the evaluation. The 
ﬁ  rst experiment evaluated the velocity by monitoring the particle 
agglomeration state using in situ light-scattering measurements. 
The second set of experiments demonstrated the formation 
of such chain-like structures in a gel model of the brain, and 
demonstrated the potential for targeted delivery by overcoming 
convective and diffusive forces. A theoretical model is developed 
to estimate the agglomeration of magnetic nanoparticles and 
calculate the effective force acting on the nanoparticles due 
to the change in effective size. The model is used to explain 
the potential of developing a process for locking magnetic 
nanoparticles in a certain region after infusion into the brain.
Materials and methods
Ferroﬂ  uids used
A ferroﬂ  uid is a liquid composed of nanoscale ferromagnetic 
or ferrimagnetic particles suspended in a carrier ﬂ  uid, usually 
an organic solvent or water. Often these particles are coated 
with organic polymers like polyethylene glycol (PEG) to 
prevent agglomeration and improve surface functionality for 
potential multimodal biomedical applications. Two types of 
nanoparticles with different sizes, morphologies and magnetic 
properties suspended in water were used in this study to create 
the ferroﬂ  uid. The ﬁ  rst nanomaterial was clustered Fe3O4 
encapsulated in a biodegradable polymer matrix (PEG-300, 
MicroMod Partikeltechnologie GmbH, Germany). Two different 
sizes, 130 nm (Product No. 09-54-132) and 250 nm (Product No. 
09-54-252) were used. The second nanomaterial was 110 nm 
pure uncoated cupro-spinel (CuFe2O4) particles synthesized 
by spray pyrolysis in a furnace aerosol reactor starting with a 
1:2 molar ratio of premixed CuSO4 and Fe(NO3)3 in aqueous 
solution. Details of the synthesis method are provided in the 
supporting document section. The concentration of particles was 
diluted using double deionized water to 1 mg ml−1 calculated 
based on total solid mass of the nanoparticles for all the 
experiments unless otherwise mentioned. Other characteristics 
of the particles used are listed in Table 1.
Experimental setup to estimate 
the velocity of nanoparticles 
in a magnetic ﬁ  eld gradient by an in situ 
light-scattering technique
A permanent magnet (7.62 × 10.16 × 12.70 cm) was utilized 
to create the magnetic ﬁ  eld gradient by using the equipolar 
xy-plane on a nonpole face of the magnet. The change in mag-
netic ﬂ  ux density and magnetic ﬁ  eld gradient as a function of 
Table 1 Size and magnetic properties of nanomaterials used
Material Mean primary 
particle size (nm)
Composition Density 
(kg m−3)
Moment 
(emu gm−1 @ 1 kOe)
Saturated moment 
(emu gm−1 @ 10 kOe)
χv (Volumetric magnetic 
susceptibility @ 1 kOe)
1 250 PEG-coated 
Fe3O4
a2500 a43.0 a67.0 1.351
2 130 PEG-coated 
Fe3O4
a3000 a43.0 a67.0 1.621
3 110 CuFe2O4
b5400 c27.5 c38.6 1.866
Notes: aSupplied by MicroMod Partikeltechnologie GmbH (Germany); bBulk density; cMeasured using Physical Property Measurement System (PPMS, Model: 6000, Quantum 
Design).International Journal of Nanomedicine 2009:4 11
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distance from its surface was measured by a Lakeshore 421 
Gauss meter with MMA-2502-VH Hall probe (Figure S2).
The velocity of the particles in the magnetic ﬁ  eld gradient 
were measured in an aqueous suspension using an in situ 
static light-scattering technique similar to that described by 
Kulkarni and colleagues.20 The optical system is comprised 
of a tungsten-ﬁ  lament lamp, a 455 nm ﬁ  lter, lenses and 
apertures to focus the light, along with a detector placed 
at 90° with respect to incident beam to monitor scattered 
light (Figure 1). 20 ml ferroﬂ  uid (1 mg ml−1) was placed in 
a Borosilicate glass sample cell (9.5 cm high × 2.5 cm inner 
diameter) with rubber-lined screw caps. The magnet was 
placed below the sample cell at different distances to vary 
the magnetic ﬁ  eld gradient. The intensity of the scattered 
light was measured at 10s time intervals after imposition 
of the magnetic ﬁ  eld gradient. The scattering intensity was 
measured at three different ﬁ  eld gradients (4.1, 3.6, and 2.0 
T m−1) and this varied due to collision and agglomeration of 
particles. Three to ﬁ  ve measurements were taken for each 
ferroﬂ  uid at each magnetic ﬁ  eld gradient for statistically 
relevant results. The travel path length for the ferroﬂ  uid 
material was kept constant (1.1 cm) and the mean time to 
traverse the path was estimated from the time taken to lose 
50% of the scattering intensity (midpoint of the slope of the 
normalized scattering intensity versus time plot). The average 
velocity (ve) of the particles in the ferroﬂ  uid was calculated 
by dividing the path length traversed by the mean time taken. 
Based on the experimentally determined velocity of the 
ferroﬂ  uid particles in the magnetic ﬁ  eld gradient, a theory 
is proposed to estimate the average number of particles in 
single agglomerate, and to calculate the effective magnetic 
force exerted on the nanoparticle agglomerates.
To support the formation of a chain-like agglomerated 
structure in the presence of a magnetic ﬁ  eld, scanning elec-
tron microscope (SEM, model Hitachi S4500) images were 
taken of the particles. The SEM samples were prepared by 
taking 0.5 ml of ferroﬂ  uid on a SEM mount (Ted Pella Inc., 
product ID 16202). The SEM mount was then placed in a 
magnetic ﬁ  eld gradient and kept for 24 hr to evaporate the 
solvents. The dry nanoparticles on the SEM mount were 
imaged to analyze the morphology.
Experimental setup to establish 
the transport of particles in a gel model 
using light microscopy
The understanding of particle transport characteristics gained 
in the preceding experiments was applied to study particle 
transport behavior in a gel model of the human brain. A 0.6% 
agarose gel was selected as the in vitro model for the experi-
ment, and has been previously validated by infusion experi-
ments within a porcine brain.21 In those experiments, the gel 
was found to have a distribution to infusion volume ratio 
28% greater than the porcine brain; with the conclusion made 
that the gel’s hydraulic conductivity was roughly 1/3 greater 
than that of the brain.21 Measurements of inter-ﬁ  ber distance 
from electron micrographs22 show a distance of 480 nm for 
a 0.6% agarose gel.
Filter
(455 nm) 
Lens
Tungsten
filament lamp 
Aperture
90° scattered
light detector 
Sample cell 
Figure 1 Experimental setup to study the transport characteristic of the ferroﬂ  uid in a controlled environment.   The magnet was placed below the sample cell at different 
distances to vary the magnetic ﬁ  eld gradient.International Journal of Nanomedicine 2009:4 12
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Incidental observation of ferroﬂ  uid in the presence of 
the magnetic ﬁ  eld gradient suggested that strong magnetic 
ﬁ  elds might hinder transport of nanoparticles within the gel 
due to particle agglomeration. Therefore, an experiment was 
devised to assess the effects of the magnetic ﬁ  eld gradient 
on transport of magnetic nanoparticles inside the pores of 
a gel. The gel was made by mixing agarose powder (Sigma 
Aldrich, St. Louis, MO) with 1 X TBE as described by Chen 
and colleagues21 and heating in the microwave until fully 
dissolved. The gel was removed, allowed to cool for ﬁ  ve 
minutes and placed into 15 ml plastic test tubes.
A microinjection pump and polyethylene tubing 
(Intramedic) with 1.22 mm outside diameter was used to 
infuse 1 mg ml−1 of 250 nm particles (material 1) suspended in 
water into the test tubes ﬁ  lled with 3 ml of gel. A total of 10 μl 
of infusate was delivered at a rate of 2 μl min−1 into the gel. 
1 ml of deionized water was placed onto the top of the gel to 
prevent dehydration and provide a small hydrostatic pressure 
to enhance transport. Four gels were placed onto the magnet 
with the bottom of the test tube resting above the pole of the 
magnet, with the vertical axis in the direction of the ﬁ  eld lines. 
For the high ﬁ  eld experiment, the particles were exposed to 
a gradient of 8.0 T m−1 while in the low ﬁ  eld experiment the 
particles experienced a gradient of 0.55 T m−1. The control 
group consisted of four gels placed outside of the magnetic 
ﬁ  eld gradient in the same vertical orientation as the experi-
mental gels.
An image of each gel was taken after infusion of the 
ferroﬂ  uid and the orientation of the test tube, along with its 
position in the ﬁ  eld, was recorded to ensure reproducibility. 
Images were obtained via a Zeiss light microscope equipped 
with a Dage-MTI CCD-72 camera. At the lowest power 
objective, a resolution of approximately 5 μm pixel−1 was 
achieved. An image from each gel and time point was 
inverted so that the dark particles corresponded to higher 
pixel values than the background. The mean and median pixel 
value of each image was then calculated for a 625 × 415 pixel 
area. The mean and median pixel value was then normalized 
for each gel, with the 0 hr value set as the baseline. All 
images were analyzed with NIH ImageJ Version 1.36b. It 
is important to note that while the gels resided for most of 
the experiment in the vertical plane, the microscope setup 
required that they be turned horizontally to be imaged. Gels 
were removed from the magnet and control area for imaging 
at 3, 6, and 16 hours and then every 16 hours after that until 
the 48 hour mark. The experiment was repeated with the 
130 nm particles (material 2) placed in both the high ﬁ  eld 
and the low ﬁ  eld regions along with the control group.
Results and discussion
A theory is proposed to estimate the particle agglomeration 
and effective force taking into account the agglomerated 
chain-like structure. The velocity of nanoparticles in an 
external magnetic ﬁ  eld gradient was determined by a static 
light-scattering technique. The experimentally measured 
velocity was used to estimate the effective particle size due 
to chaining based on the proposed theory. The transport of 
nanoparticles in a gel model was then established.
Theoretical estimation of particle 
agglomeration and effective force acting 
on particles in ferroﬂ  uid in magnetic ﬁ  eld 
gradient
Two forces act on a single nanoparticle suspended in a ﬂ  uid 
medium in the magnetic ﬁ  eld gradient – the magnetic force 
and the drag force. The terminal velocity (vt,1) in a magnetic 
ﬁ  eld gradient can be readily obtained based on a single par-
ticle force balance as reported by Holligan and colleagues18 
and Kuhn and colleagues19
  v
d
t
vp
,l =
χ δ
ημ
Β
22
0 36   (1)
where, χv is the volumetric magnetic susceptibility of 
the nanoparticle, δΒ  is the magnetic ﬁ  eld gradient, dp is the 
mean diameter of the primary nanoparticle, η is the viscosity 
of the ﬂ  uid medium into which the particles are injected, and 
μ0 is the permeability of free space.
However, when placed in a magnetic ﬁ  eld gradient, the 
ferromagnetic particles in the ferroﬂ  uid interact with each 
other and form agglomerated structures. The morphology 
of these agglomerates formed by collision of nanoparticles 
in an external magnetic ﬁ  eld gradient typically results in a 
chain-like structure. Thus the terminal velocity calculated 
based on the force balance on a single particle is expected 
to under predict the actual velocity of the particles due to a 
change in the effective size (that will alter both the magnetic 
force and the drag force). To account for the chaining of 
nanoparticles due to collisions in the magnetic ﬁ  eld gradi-
ent, a modiﬁ  ed magnetic force and drag force expression is 
proposed. Assuming each chain-like agglomerate is made 
up of an average of “n” number of primary particles with 
mean diameter dp, the modiﬁ  ed magnetic force (Fm,c) can 
be given by,
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The drag force on a nonspherical structure can be 
estimated by extending the Navier–Stokes equation for drag 
on an isolated sphere in creeping ﬂ  ow.23–25 A detailed drag 
force expression proposed by Leith25 for nonspherical shape 
particles is used to estimate the drag force on the chain-like 
magnetic nanoparticle agglomerate (Fd,c),
  Fv d
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where vt,c is the terminal velocity for a chain-like structure, 
dn is the diameter of the sphere with same projected area 
as the area of the particle projected normal to its direction 
of motion, ds is the diameter of the sphere whose effective 
surface equals that of the particle. For a chain-like structure 
formed by agglomeration of “n” particles in a linear manner 
with mean diameter of each primary particle being dp, dn 
can be replaced with dp and ds can be replaced by nd p
12 / . 
Thus the drag force for a chain-like structure (Eq. 3) 
becomes
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The terminal velocity for a chain-like structure (vt,c) in 
a magnetic ﬁ  eld gradient can be calculated by equating the 
modiﬁ  ed magnetic force (Eq. 2) to drag force (Eq. 4) as
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Based on proposed derivation, it is clear, that the ter-
minal velocity for a chain-like agglomerated structure is 
enhanced by a factor dependent on the number of primary 
particles in the agglomerate. The theoretically calculated 
terminal velocity in the magnetic ﬁ  eld gradient based on 
single particle force balance always underestimate the 
actual velocity of particles in the presence of an external 
magnetic ﬁ  eld gradient. Furthermore, the expression for the 
terminal velocity for a chain-like structure (Eq. 5) can be 
solved to estimate the average number of primary particles 
in agglomerate as
The equation for the number of primary particles in an 
agglomerate can be further simpliﬁ  ed as
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where ξ is a dimensionless magnetic velocity enhancement 
factor given as v v tc tl ,, / . The estimated number of primary 
particles in an agglomerate (Eq. 6 or 7) can be used to cal-
culate the effective force acting on a chain-like agglomerate 
using Equation 2.
The proposed theory based on creeping flow of a 
nonspherical shape particle falls within the laminar ﬂ  ow region 
of Reynolds number calculated based on experimental velocity 
and mean agglomerate particle size. The use of average n num-
ber of primary particles in a chain-like structure to calculate 
the effective magnetic force can be justiﬁ  ed by comparing 
the characteristic time to form the chain-like morphology 
with that required to attain the terminal velocity in a magnetic 
ﬁ  eld gradient. The characteristic time for terminal velocity in 
a magnetic ﬁ  eld gradient (τm) is calculated by estimating the 
time to travel a distance of 1 cm, based on a single particle 
force balance. The characteristic time for forming chain-like 
structures due to collisions in a magnetic ﬁ  eld gradient can 
be estimated by an analytical expression given by Kumar 
and colleagues.26 Assuming the interacting particles form 
a chain-like agglomerate in a magnetic ﬁ  eld gradient, the 
collision frequency function in the free molecular regime 
(βFM) is given by
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where B is the magnetic ﬂ  ux density, kB is the Boltzmann 
constant, T is the temperature, and ρp is the density of the 
nanoparticles. The expression for the collision frequency 
function (Eq. 8) can be further simplified based on a 
monodisperse particle assumption (ie, ddd ijp ==  and 
χχχ ijv == )
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The characteristic time for magnetic coagulation (τc) can 
then be calculated as τ β co F M =1/( ), Ν  where No is the initial 
concentration of nanoparticles.
Experimental measurement of velocity 
of particles in a ferroﬂ  uid in a magnetic 
ﬁ  eld gradient by in situ static light 
scattering technique: Estimation 
of chaining and effective magnetic force
The intensity of scattered light for the 110 nm ferroﬂ  uid was 
normalized to initial time (t = 0 s) and plotted against time 
(Figure 2). There are two clearly distinguishable plateaus that 
can be identiﬁ  ed in this ﬁ  gure. The decrease in normalized 
intensity (normalized at t = 0 s) followed by the plateau at 
t  100 s is thought to be caused by changes in the morphology 
of the agglomerated particles due to the external magnetic 
ﬁ  eld gradient (Figure S3). When initially placed in a magnetic 
ﬁ  eld gradient, the particles tend to form an ordered chain-like 
morphology compared to its initial random unagglomerated 
morphology. A drop in scattering intensity is expected due 
to this morphology change that results in a decrease in the 
particle number concentration. The continued decrease in 
normalized intensity (normalized at t = 100 s) followed by 
the second plateau at t  100 s results from a decrease in the 
absolute concentration of the particles due to magnetic mobi-
lization and settling of the ferroﬂ  uid particles (Figure S4). 
The drop in scattering intensity due to formation of chain-like 
structures due to collision of particles in the magnetic ﬁ  eld 
gradient is a reversible process (on removal of ﬁ  eld), while 
the drop in scattering intensity due to settling is irreversible 
(loss of particles from view volume). The time scale (τc) to 
reorganize the morphology by collision of particles for all 
materials in different external magnetic ﬁ  elds were theoreti-
cally calculated and plotted in Figure 3 based on the properties 
of the materials listed in Table 1. The calculated characteristic 
time for agglomeration due to collisions was found to be on 
the order of ∼10−3 s, which is similar to the experimentally 
measured value by Fernandes and colleagues.27 The estimated 
characteristic time for velocity (τm) in an external magnetic 
ﬁ  eld gradient is on the order of ∼103 s (Figure 3). The order 
of magnitude analysis of the characteristic time for agglom-
eration by collisions and particle velocity clearly justiﬁ  es the 
use of a chain-like structure to estimate the true velocity of 
chain-like agglomerates. It also suggests that the two plateaus 
found in the plot of normalized scattering intensity versus 
time (Figure 2) are caused by two different phenomena: the 
ﬁ  rst one due to collisional growth in magnetic ﬁ  elds, while 
the second one is due to settling under the inﬂ  uence of the 
magnetic ﬁ  eld gradient. The same trend is seen in the plot 
of initial normalized scattering intensity versus time for the 
other two materials (Figures S5 and S6).
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Figure 2 Variation of normalized scattering intensity (normalized at t = 0s) with time for material 3 (110 nm ferroﬂ  uid) at various applied magnetic ﬁ  eld gradient.International Journal of Nanomedicine 2009:4 15
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Variation of scattering intensity normalized to t = 100 s 
(Figure S3) is used to estimate the velocity of 110 nm particles 
in the external magnetic ﬁ  eld gradient listed in Table 2. 
Similarly, the velocity of 130 nm and 250 nm particles 
in the ferroﬂ  uid is estimated from the plot of scattering 
intensity normalized to t = 30 s (Figure 4). The scatter-
ing intensity normalized to t = 0 s for these materials are 
provided in Supporting information (Figures S5 and S6). 
A different time is used to normalize the scattering intensity 
for the 130 nm and 250 nm ferroﬂ  uid (t = 30 s) compared 
to 110 nm ferroﬂ  uid (t = 100 s). The time is chosen based 
on experimental measurements close to the actual position 
of the ﬁ  rst plateau. The properties of the materials listed 
in Table 1 are used in equation 1 to theoretically predict 
the terminal velocity based on a single particle force bal-
ance in water in the presence of an external magnetic ﬁ  eld 
gradient (Table 2). A plot of the experimentally measured 
and theoretically predicted velocity as a function of the 
magnetic ﬁ  eld gradient is shown in Figure 5. It is of note that 
the experimentally measured velocity exceeded the predicted 
values by as little as a factor of ∼3 and as much as a factor of 
∼10. This is attributed to the agglomeration of particles while 
in the magnetic ﬁ  eld gradient, giving the particles a larger 
effective size and therefore experiencing a larger effective 
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Figure 3 Comparison of characteristic time of collisional growth in magnetic ﬁ  eld (τc) and characteristic time to traverse 1 cm (τm) for different ferroﬂ  uids at various mag-
netic ﬁ  eld gradients.
Table 2 Experimental matrix to study the transport characteristic of different ferroﬂ  uid in controlled environment
Material Magnetic ﬁ  eld gradient 
(T m−1)
Particle velocity (cm s−1) ve/vt Estimated number of 
primary particles in 
each agglomerate (n)
Experimental (ve) Theoretical (vt,1)
1
4.1 1.0 × 10−2 3.5 × 10−3 3.0 6
3.6 8.5 × 10−3 2.7 × 10−3 3.1 6
2.0 5.2 × 10−3 8.6 × 10−4 6.1 22
2
4.1 4.6 × 10−3 1.1 × 10−3 4.0 10
3.6 3.3 × 10−3 8.8 × 10−4 3.8 9
2.0 2.0 × 10−3 2.8 × 10−4 7.3 32
3
4.1 4.6 × 10−3 9.5 × 10−4 4.8 14
3.6 3.3 × 10−3 7.2 × 10−4 4.6 13
2.0 2.3 × 10−3 2.3 × 10−4 10.0 58International Journal of Nanomedicine 2009:4 16
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magnetic force. The experimentally measured velocity at a 
ﬁ  xed magnetic ﬁ  eld gradient is a function of mean primary 
particle size; hence, the velocity is higher for bigger particles. 
Further, for same particle sizes, the velocity is a function 
of the applied magnetic ﬁ  eld gradient. These ﬁ  ndings are 
consistent with the proposed model of force balance on 
chain-like agglomerates.
The experimentally estimated velocities were used to 
estimate the average number of primary particles in each 
chain-like agglomerate based on Equation 6. The effective 
force acting on the agglomerates was determined using 
Equation 3 (Table 2). The number of primary particles 
in the agglomerate (n) was found to be a function of the 
magnetic ﬁ  eld gradient, the primary particle size, and its 
underlying material composition. The number of primary 
particles in an agglomerate decrease as the magnetic ﬁ  eld 
gradient and mean primary particle size increases. The 
uncoated nanoparticle (material 3) was found to form larger 
agglomerates compared to the similar sized PEG-coated 
material (material 2). High resolution scanning electron 
micrographs were taken of all materials and provided 
direct evidence of chaining. Figure 6 shows the difference 
in particle alignment and distribution after drying inside 
and outside the high magnetic ﬁ  eld gradient region. The 
particles that dried outside the magnetic ﬁ  eld gradient 
appear in a more random orientation, while those dried in 
the ﬁ  eld appear to chain and an agglomerate. The effective 
magnetic force is higher than the force calculated without 
any agglomeration by a factor n. As the number of primary 
particles in agglomerate is found to have an inverse relation 
with the applied magnetic ﬁ  eld gradient, it can be concluded 
that even a small magnetic ﬁ  eld gradient can generate 
a very high effective force on magnetic nanoparticles due 
to enhanced agglomeration.
In vitro transport characteristic 
of ferroﬂ  uid in a gel model of the brain 
using light microscopy
After taking images of the test tubes at 0, 3, 6, 16, 32, and 
48 hours, the data was analyzed and normalized with ImageJ. 
The normalized pixel values for each series of gels at a given 
time point was averaged and the results displayed in Figure 7. 
The inherent assumption in this analysis is that a higher concen-
tration of particles in an image, whether they are in or out of the 
plane of focus, will contribute to a higher average pixel value. 
Therefore, the mean pixel value was used as a proxy for total 
particle concentration in a given image. As particles diffuse 
away from the original infusion site, the overall concentration 
of particles for any given area of the image will decrease, lead-
ing to a lower mean pixel value. The results in Figure 7 suggest 
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that the highest magnetic ﬁ  eld gradient (8.0 T m−1) retains 
more particles in the image. As the ﬁ  eld strength decreases, 
the loss in average pixel value over time indicates diffusion 
of particles for both the materials. However, it is to be noted 
that, even a ﬁ  eld as small as 0.55 T m−1 can be partially effec-
tive to hinder the free diffusion of the nanoparticle due to 
higher effective size as a result of collisional growth in the 
magnetic ﬁ  eld gradient. One way to validate the above data 
is to examine the histograms of pixel values in the image over 
time (Figure S7). Initially stratiﬁ  ed across the spectrum of pixel 
values, after 48 hours the control gel appears to converge, most 
likely onto the background (baseline) value. The gel exposed International Journal of Nanomedicine 2009:4 19
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to the magnetic ﬁ  eld gradient however retains a remarkably 
similar distribution to the 0 hour histogram. This would seem 
to indicate that the particles remain concentrated in the pres-
ence of the magnetic ﬁ  eld gradient, in agreement with the data 
in Figure 7. Further, the decrease in normalized pixel value 
for 250 nm particles is greater compared to 130 nm particles 
at the same applied ﬁ  eld, which may be an artifact of the 
experiments. Since the experiment is designed with the same 
initial concentration of ferroﬂ  uid (1 mg ml−1), the number 
concentration of the 130 nm sample is higher compared to the 
250 nm samples. Due to higher overall projected surface area, 
the 130 nm sample contributes more towards the pixel value 
than the same amount of 250 nm sample.
Unfortunately, due to our desire to utilize the same particles 
analyzed in the experiments for velocity measurements, 
diffusion analysis was not done with one of the more accepted, 
and analytically rigorous methods proposed in the literature, 
such as ﬂ  uorescence recovery after photobleaching (FRAP).28,29 
Because of this, transport of particles in the gels is compared 
only qualitatively using an optical imaging technique. However, 
the proposed model clearly indicates that particles with a larger 
effective size will experience signiﬁ  cant reductions in transport 
(diffusivity) in the magnetic ﬁ  eld gradient due to agglomeration. 
The assertion that the particles are agglomerating is supported 
by the SEM results (Figure 6), as well as the high magniﬁ  cation 
light microscope results (Figure S8).
The results described seem to indicate that bulk ﬂ  ow of 
particles due to magnetic ﬁ  elds, as demonstrated by Kuhn and 
Holligan at 45.0 T m−1, does not occur in our in vitro model 
at gradients less than 10.0 T m−1. However, Goodwin4 noted 
that after a two hour magnetic exposure, the distribution 
of particles remained approximately the same for at least 
a further two hours after removing the magnet, indicating 
hindered diffusion. Goodwin’s ﬁ  ndings4 agree with the results 
of the diffusion experiments outlined above. The effective 
size of the particles is drastically increased by collisional 
growth forming a chain-like agglomerate as demonstrated 
in previous sections. Therefore, in our experiments the 
agglomerate of particles appears to diffuse much more slowly, 
hindering the diffusion of particles. The dependence of size 
on diffusivity has been conﬁ  rmed with various in vivo and 
in vitro studies.11,30,31 Ohata and colleagues28 demonstrated that 
diffusion plays a role in spread of macromolecules through 
the cortex, and this phenomenon is dependent on size. In fact, 
Kuhn19 characterized the movement of superparamagnetic 
nanoparticles through extracellular matrix from murine 
sarcoma and found that the velocity of 135 nm particles was 
more than 100 times that of 400 nm particles.
This has tremendous implications for therapeutic use in 
the brain. In theory, small magnetic nanoparticles, approxi-
mately 50 nm or below, could be infused via CED to cover 
a large percentage of the intended target, as demonstrated by 
Muldoon.29 Then, the particles might be effectively locked 
into place by exposing the region to a high magnetic ﬁ  eld 
gradient. The resulting agglomeration due to collisions in 
the magnetic ﬁ  eld gradient increase the effective size and 
slow or prevent further passive diffusion of the particles. 
If diffusion plays a dominant role in the clearance of the 
particles, this could prove to be a method to signiﬁ  cantly 
increase the local concentration. Even when diffusion is not 
the primary mode of clearance, agglomeration within the 
magnetic ﬁ  eld gradient could play a role by inhibiting the 
convective process. Results from the velocity experiments 
suggest that the agarose ﬁ  bers in a 0.6% agarose gel provide 
an effective barrier to movement of particles greater than or 
equal to 130 nm in diameter within a magnetic ﬁ  eld gradient. 
Chen21 showed that the hydraulic conductivity was actually 
greater in the agarose model than in porcine brain, which 
suggests that the inability to move the nanoparticles might 
also occur with the in vivo situation.
However, given the diffusion and conductivity differences 
between different parts of the brain, the success of this 
inhibition could vary depending on the area in which it is 
deployed and the speciﬁ  c extracellular geometry of that 
region. Conversely, if smaller particles are infused via CED, it 
might be possible to maneuver them through the brain tissue 
using magnetic ﬁ  elds. Muldoon and colleagues29 found that 
60–185 nm ferumoxide particles did not leak into rat tumors, 
while 20–50 nm particles did. The CED of 40 nm and 90 nm 
liposomes into glioma xenografts was detailed by Mamot and 
colleagues.11 The 40 nm liposomes were distributed through-
out most of the tumor, and this effect was enhanced with the 
addition of mannitol, causing the liposomes to spread beyond 
the tumor boundaries. The 90 nm liposomes achieved just 
over 50% coverage after the addition of mannitol, suggesting 
that larger sizes reduced spread. The particle’s size, coating, 
and magnetic properties will all be factors that could deter-
mine whether smaller particles aggregate and demonstrate 
decreased diffusion, or whether the particles might be actively 
moved with magnetic field manipulation. The gradient 
strength could also be an important factor in determining the 
tradeoff between these two possibilities.
Conclusions
A technique to determine the velocity of particles when a 
ferroﬂ  uid is exposed to magnetic ﬁ  elds was established. International Journal of Nanomedicine 2009:4 20
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It has been demonstrated that the velocity of magnetic 
nanoparticles suspended in a ﬂ  uid medium when exposed 
to a magnetic ﬁ  eld gradient is enhanced due to an increase 
in effective size by collisional growth. A model was devel-
oped and used to estimate the effective size and the effective 
magnetic force acting on the agglomerate based on force 
balance on chain-like agglomerate structures. Further, it has 
been demonstrated that magnetic nanoparticles greater than 
or equal to 130 nm in diameter prove very difﬁ  cult to guide 
through an in vitro model of the brain tissue. Result suggests 
that low magnetic ﬁ  eld gradients (below 10 T m−1) could be 
used to limit passive diffusion, and possibly slow convection 
of nanoparticles within the brain due to agglomeration of 
particles. This could have many therapeutic beneﬁ  ts when 
combined with convection enhanced delivery of magnetic 
nanoparticles. Future work should be carried out with a 
more quantitative approach to measuring diffusion, and an 
in vivo model should be used to validate the results of the 
agarose gel.
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Nomenclature and Greek 
characters
B, magnetic ﬂ  ux density (T); dn, diameter of the sphere with 
same projected area as the area of the particle projected 
normal to its direction of motion (m); dp, mean diameter of 
primary nanoparticle (m); ds, diameter of the sphere whose 
effective surface equals that of particle (m); Fd,c, drag force 
acting on a chain-like agglomerate with n number of particles 
of diameter dp (N); Fm,c, magnetic force acting on a chain-like 
agglomerate with n number of particles of diameter dp (N); 
kB, Boltzmann constant (J K−1); n, average number of primary 
particles in each agglomerate; No, initial number concentration 
of nanoparticles (# m−3); T, temperature (K); vt,1, terminal 
velocity in magnetic ﬁ  eld gradient calculated based on single 
particle force balance (m s−1); vt,c, terminal velocity of a chain-
like agglomerate with n number of particles of diameter dp in 
magnetic ﬁ  eld gradient (m s−1); βFM, the collision frequency 
function in free molecular regime assuming the interacting 
particles form a chain-like agglomeration in a magnetic 
ﬁ  eld gradient (# s−1); δB, magnetic ﬁ  eld gradient (T m−1); 
η, viscosity of the ﬂ  uid medium into which the particles are 
injected (N s m−2); μo, permeability of free space; ξ, ratio of 
terminal velocity in magnetic ﬁ  eld gradient calculated based 
on force balance on chain-like structure to the velocity cal-
culated based on force balance on single particle () ,, vv tc tl / ; 
ρp, density of the nanoparticles (kg m−3); τc, characteristic 
time for magnetic coagulation (s−1); τt, characteristic time for 
terminal velocity (s−1); χv, volumetric magnetic susceptibility 
of the nanoparticle.
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Figure S1 Hysteresis loop for synthesized 110 nm CuFe2O4 at 300 K measured using a Quantum Design PPMS SQUID (model 6000).
Supporting information
Experimental setup for nanoparticle 
synthesis
The experimental setup for synthesis of nanocomposite 
consisted of three components. A nebulizer was used as a 
precursor feeding system, a tubular furnace aerosol reactor 
(FuAR, Lindbergh BlueM model STF54779C, effective 
length 106 cm and internal diameter 2.5 cm) was used to 
decompose the precursor and an electrostatic precipitator 
(ESP) was used for particle collection. Aqueous solution of 
Fe(NO3)3 and CuSO4 (2:1 molar ratio) was nebulized and 
carried by air into the FuAR and was decomposed at differ-
ent temperatures (1000–1200οC). Air at different ﬂ  ow rate 
was used to provide an oxidizing atmosphere, and to control 
the residence time inside the reactor. Precursor concentra-
tion (0.1–1 M) was varied to produce particles between 
70–200 nm mobility diameter. The synthesized particles 
were collected on a cylindrical ESP with applied potential 
of +10 kV.
Particle mobility size distribution was measured at the 
exit of FuAR using a scanning mobility particle sizer (SMPS, 
Model: TSI 3936) system. The size and microstructures were 
veriﬁ  ed by a SEM (Model JEOL 7001LVF FE-SEM). The 
crystallographic characteristics were analyzed by powder 
XRD technique (Model: Rigaku D-MAX/A9 diffractometer, 
Cu Kα radiation, λ = 1.5418 Å).International Journal of Nanomedicine 2009:4 23
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Figure S4 Variation of normalized scattering intensity (normalized at t = 100 s) due to velocity for material 3 (110 nm ferroﬂ  uid) at various applied magnetic ﬁ  eld gradient.
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Figure S6 Variation of normalized scattering intensity (normalized at t = 0 s) with time for material 1 (250 nm ferroﬂ  uid) at various applied magnetic ﬁ  eld gradient.
a b
d c
0 256 0 256
0 256 0 256
Figure S7 Histograms of control gel infused with 130 nm particles at 0 hrs (a) and 48 hrs (b), and gel infused with 130 nm particles at (c) 0 hrs and (d) after 48 hrs in the 
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Figure S8 Images of 110 nm particles (material 3) placed into middle of gel after punching with a needle before being placed into the magnetic ﬁ  eld (left) and after 23 hours 
in the magnetic ﬁ  eld (right).